Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.
- DOI
- 10.1177/10781552261497638
- Published
- 2026 Oct 30
- Container
- Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/10781552261497638,
title = {Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.},
author = {Cruz Castillo Y and Chen Liang A and Samperio VM and Bentley A and Roberts Trinidad EO and Codreanu I and Dasanu CA},
year = {2026},
journal = {Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners},
doi = {10.1177/10781552261497638},
url = {https://doi.org/10.1177/10781552261497638}
}RIS
TY - JOUR TI - Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. AU - Cruz Castillo Y AU - Chen Liang A AU - Samperio VM AU - Bentley A AU - Roberts Trinidad EO AU - Codreanu I AU - Dasanu CA PY - 2026 JO - Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners DO - 10.1177/10781552261497638 UR - https://doi.org/10.1177/10781552261497638 ER -
APA
Y, C. C., A, C. L., VM, S., A, B., EO, R. T., I, C., & CA, D. (2026). Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis.. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. https://doi.org/10.1177/10781552261497638
Source records
- pubmed · retrieved 2026-11-11T01:56:29.836Z